On August 24, JD HEALTH fell 3.41% in regular trading, trading at HK$37.34/share, with turnover of HK$52.99 million.

The decline was primarily driven by a broad selloff across the Hong Kong internet and retail sector. BABA-W led the sector lower with a 10.41% drop, while MEITUAN-W fell 2.59%, JD-SW declined 2.52%, ALI HEALTH dropped 2.76%, and PA GOODDOCTOR slid 1.48%, reflecting clear systematic selling pressure across the board.

On the fundamental side, JD HEALTH reported solid interim results on August 13, with first-half revenue of RMB 40.9 billion, up 15.9% year-over-year, and Non-IFRS operating profit of RMB 3.5 billion, up 40.3% year-over-year. Multiple investment banks maintain buy ratings, with CICC setting a target price of HK$66.2 and Nomura at HK$60. The current pullback appears driven by sector-wide risk-off sentiment rather than company-specific factors.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)